摘要
目的探讨慢性心力衰竭患者甲状腺功能(T3、T4、FT3、FT4、TSH)水平的变化。方法心力衰竭组:通过测定44例慢性充血性心力衰竭患者抗心力衰竭治疗前的血清T3、T4、FT3、FT4、TSH水平,对照组:与45例健康体检者血清T3、T4、FT3、FT4、TSH水平比较。结果心力衰竭组T3、FT3较对照组下降(P<0.05),T4、FT4仅在重度心力衰竭时下降(P<0.05),而TSH在两组间无明显差异;抗心力衰竭治疗后,T3、FT3水平明显上升(P<0.05)。结论 T3、FT3可作为反映慢性充血性心力衰竭严重程度、治疗效果和预后的一项判定指标。
Objective To research into the changes of thyroid（T3,T4,FT3,FT4,TSH） levels of chronic heart failure patients.Methods Heart failure group： Measured the serum T3,T4,FT3,FT4,TSH levels of 44 chronic congestive heart failure patients before heart failure interference treatment.Comparison group： Compared against the serum T3,T4,FT3,FT4,TSH levels of 45 health check customers.Results Compared with the comparison group,the T3 and FT3 levels of heart failure group dropped（P0.05）,T4 and FT4 levels dropped only in severe heart failure（P0.05）,while there is no distinctive difference in the TSH level of the two groups.After heart failure interference treatment,the T3 and FT3 levels significantly increased（P0.05）.Conclusion T3 and FT3 can be determination indexes for reflecting chronic congestive heart failure degree,treatment effects and prognosis.
出处
《中国医药指南》
2011年第23期29-30,共2页
Guide of China Medicine
